{"id":"thyrotropin-releasing-hormone","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"TRH acts on the thyrotroph cells in the anterior pituitary gland by binding to its G-protein coupled receptors, leading to increased intracellular calcium levels and subsequent secretion of TSH, which then regulates thyroid hormone production.","oneSentence":"Thyrotropin-releasing hormone stimulates the release of thyroid-stimulating hormone (TSH) from the anterior pituitary gland.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:10.032Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypothyroidism due to insufficient TSH production"},{"name":"Diagnostic testing of pituitary function"}]},"trialDetails":[{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT04868045","phase":"PHASE1","title":"Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer","status":"WITHDRAWN","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-04-27","conditions":"Thyroid Cancer","enrollment":""},{"nctId":"NCT03660813","phase":"NA","title":"Follicle Size and Oocyte Development","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2018-07-01","conditions":"IVF Treatment","enrollment":200},{"nctId":"NCT00454220","phase":"PHASE2","title":"Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2007-07","conditions":"Multinodular Goiter","enrollment":96},{"nctId":"NCT02399475","phase":"NA","title":"Mechanistic Study of Subclinical Hypothyroidism In the Elderly","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2015-01-01","conditions":"Subclinical Hypothyroidism","enrollment":14},{"nctId":"NCT01557504","phase":"PHASE1","title":"A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-07-18","conditions":"Type 2 Diabetes Mellitus","enrollment":25},{"nctId":"NCT01970098","phase":"PHASE3","title":"A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"2013-10-09","conditions":"Spinocerebellar Degeneration","enrollment":374},{"nctId":"NCT00054756","phase":"PHASE2","title":"Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2003-02-07","conditions":"Healthy, Pituitary Disease, Thyroid Disease","enrollment":96},{"nctId":"NCT01110707","phase":"PHASE2","title":"A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-01-10","conditions":"Infertility, Ovulation Induction","enrollment":131},{"nctId":"NCT02069808","phase":"PHASE4","title":"Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation","status":"COMPLETED","sponsor":"Michigan Reproductive Medicine","startDate":"2014-04","conditions":"Egg Donation","enrollment":38},{"nctId":"NCT00790296","phase":"PHASE2","title":"Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue","status":"TERMINATED","sponsor":"UConn Health","startDate":"2006-12","conditions":"Cancer-related Fatigue","enrollment":11},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT00812149","phase":"","title":"Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2008-12-17","conditions":"Thyroid Disease, Healthy","enrollment":86},{"nctId":"NCT01970137","phase":"PHASE3","title":"A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"","conditions":"Spinocerebellar Degeneration","enrollment":""},{"nctId":"NCT01970111","phase":"PHASE3","title":"An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"","conditions":"Spinocerebellar Degeneration","enrollment":""},{"nctId":"NCT01970124","phase":"PHASE3","title":"A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"","conditions":"Spinocerebellar Degeneration","enrollment":""},{"nctId":"NCT00137891","phase":"PHASE1","title":"Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2005-06","conditions":"Healthy","enrollment":46},{"nctId":"NCT00106119","phase":"PHASE2","title":"Thyroid and Glucose and Energy Metabolism","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2005-03","conditions":"Thyroid Diseases","enrollment":18},{"nctId":"NCT01185704","phase":"PHASE3","title":"Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Polycystic Ovarian Syndrome","enrollment":136},{"nctId":"NCT01210144","phase":"PHASE4","title":"EXpression PRofile Endometrium Samples Study","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"In Vitro Fertilization","enrollment":27},{"nctId":"NCT01384435","phase":"PHASE2","title":"A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"","conditions":"SCD","enrollment":200},{"nctId":"NCT00884221","phase":"PHASE3","title":"MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2009-07","conditions":"Infertility","enrollment":749},{"nctId":"NCT01004016","phase":"PHASE2","title":"A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"","conditions":"Spinocerebellar Degeneration","enrollment":20},{"nctId":"NCT00863538","phase":"PHASE2","title":"Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"","conditions":"Spinocerebellar Degeneration","enrollment":40},{"nctId":"NCT00669786","phase":"PHASE3","title":"Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"","conditions":"Ovarian Stimulation","enrollment":""},{"nctId":"NCT00004778","phase":"PHASE3","title":"Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"1993-08","conditions":"Respiratory Distress Syndrome","enrollment":1090},{"nctId":"NCT00004840","phase":"NA","title":"Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1998-05","conditions":"Respiratory Distress Syndrome","enrollment":996}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"ILLNESS"},{"count":1,"reaction":"OBSTRUCTIVE AIRWAYS DISORDER"},{"count":1,"reaction":"SALIVARY HYPERSECRETION"},{"count":1,"reaction":"STATUS EPILEPTICUS"},{"count":1,"reaction":"TOXICITY TO VARIOUS AGENTS"}],"_approvalHistory":[],"publicationCount":7193,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"thyrotropin-releasing hormone","genericName":"thyrotropin-releasing hormone","companyName":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","companyId":"eunice-kennedy-shriver-national-institute-of-child-health-and-human-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Thyrotropin-releasing hormone stimulates the release of thyroid-stimulating hormone (TSH) from the anterior pituitary gland. Used for Hypothyroidism due to insufficient TSH production, Diagnostic testing of pituitary function.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}